10x Genomics Inc (NAS:TXG)
$ 24.83 -0.18 (-0.72%) Market Cap: 2.97 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 76/100

Q3 2021 10X Genomics Inc Earnings Call Transcript

Nov 03, 2021 / 08:30PM GMT
Release Date Price: $164.16 (+1.33%)
Operator

Hello, and welcome to the 10x Genomics Third Quarter 2021 Earnings Call. My name is Charlie, and I will be coordinating your call today. (Operator Instructions)

I will now hand you over to your host, Eric Jaschke, Senior Director of Investor Relations and Strategic Finance to begin. Eric, please go ahead.

Eric Jaschke

Thank you. Earlier today, 10x Genomics released financial results for the third quarter ended September 30, 2021. If you've not received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. An archived webcast of this call will be available on the Investors tab of the company's website, 10xgenomics.com, for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot